摘要 |
<p>Disclosed is the process for the synthesis of the compound of formula (I) and its pharmaceutically acceptable salts thereof characterised in that a compound of formula (II) wherein R1 represents a hydrogen atom or a benzyl or linear or branched (C1-6)alkyl group, is reacted with a compound of formula (III) having an S configuration wherein X represents a halogen atom and R2 represents a protecting group for the amino function, in the presence of a base, to yield, after deprotection of the amino function, a compound of formula (IV) wherein R1 is as defined hereinbefore, which is reacted with a compound of formula (V) wherein G represents a chlorine, bromine or iodine atom or a p-toluenesulfonyloxy, methanesulfonyloxy of trifluoromehtansulfonyloxy group, in the presence of a base, to yield a compound of formula (VI) wherein R1 is as defined hereinbefore, which is hydrogenated in the presence of a catalyst such as palladium, platinum, rhodium or nickel to yield, after deprotection where necessary, the compound of formula (I).</p> |